Arun Swaminathan
Fortune : 45 600 $ au 31/08/2026
Fortune : 45 600 $ au 31/08/2026
Dr. Arun Swaminathan is a Chief Executive Officer & Director at Coya Therapeutics, Inc. He is on the Board of Directors at Coya Therapeutics, Inc. Dr. Swaminathan was previously employed as a Chief Business Officer by Actinium Pharmaceuticals, Inc., a Chief Business Officer & Senior Vice President by Alteogen, Inc., a Chief Executive Officer by Lynkogen, Inc., a Director-Worldwide Brand by Bristol Myers Squibb Co., and a Head-Marketing by Labcorp Drug Development, Inc. He received his undergraduate degree from the University of Madras and a doctorate degree from the University of Pittsburgh.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/05/2026 | 10 000 ( 0,04% ) | 45 600 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| COYA THERAPEUTICS, INC. | Directeur Général | 01/11/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2023 |
| ALTEOGEN INC. | Corporate Officer/Principal | 01/09/2021 |
Lynkogen, Inc. | Directeur Général | 01/03/2020 |
| COVANCE INC. | Sales & Marketing | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Labcorp Drug Development, Inc.
Labcorp Drug Development, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory testing and drug development services | Health Services |
University of Pittsburgh
University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Madras
University of Madras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Alteogen, Inc.
Alteogen, Inc. BiotechnologyHealth Technology Engages in the research and development of biopharmaceuticals | Health Technology |
Coya Therapeutics, Inc.
Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells | Health Technology |
Lynkogen, Inc. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national